Cargando…
Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
BACKGROUND: Pirfenidone is an antifibrotic compound able to slow down disease progression in patients with idiopathic pulmonary fibrosis (IPF). OBJECTIVE: To investigate the safety and efficacy of pirfenidone in patients with IPF in a real-life setting. METHODS: This was a multicenter, retrospective...
Autores principales: | Tzouvelekis, Argyrios, Karampitsakos, Theodoros, Ntolios, Paschalis, Tzilas, Vasilios, Bouros, Evangelos, Markozannes, Evangelos, Malliou, Ioanna, Anagnostopoulos, Aris, Granitsas, Andreas, Steiropoulos, Paschalis, Dimakou, Katerina, Chrysikos, Serafeim, Koulouris, Nikolaos, Bouros, Demosthenes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712559/ https://www.ncbi.nlm.nih.gov/pubmed/29238708 http://dx.doi.org/10.3389/fmed.2017.00213 |
Ejemplares similares
-
Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018) -
The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
por: Ntolios, Paschalis, et al.
Publicado: (2021) -
False Positive COVID-19 Antibody Test in a Case of Granulomatosis With Polyangiitis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2020) -
Metabolic Disorders in Chronic Lung Diseases
por: Papaioannou, Ourania, et al.
Publicado: (2018) -
Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)